Vyome Holdings, Inc. (NASDAQ:HIND) Sees Significant Increase in Short Interest

Vyome Holdings, Inc. (NASDAQ:HIND) was the target of a large growth in short interest during the month of January. As of January 30th, there was short interest totaling 260,650 shares, a growth of 220.8% from the January 15th total of 81,249 shares. Based on an average trading volume of 4,310,075 shares, the days-to-cover ratio is presently 0.1 days. Currently, 6.9% of the shares of the company are short sold. Currently, 6.9% of the shares of the company are short sold. Based on an average trading volume of 4,310,075 shares, the days-to-cover ratio is presently 0.1 days.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (e-)” rating on shares of Vyome in a research report on Monday, December 29th. Two research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $15.00.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Vyome stock. Geode Capital Management LLC bought a new position in shares of Vyome Holdings, Inc. (NASDAQ:HIND) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 11,934 shares of the company’s stock, valued at approximately $41,000. Geode Capital Management LLC owned 0.21% of Vyome at the end of the most recent reporting period. 22.06% of the stock is owned by institutional investors.

Vyome Trading Down 0.8%

HIND stock traded down $0.02 on Friday, hitting $2.59. 123,537 shares of the company’s stock were exchanged, compared to its average volume of 1,701,124. The firm has a market capitalization of $14.61 million, a PE ratio of -0.02 and a beta of 1.50. The stock’s 50 day simple moving average is $3.34. Vyome has a 12-month low of $1.75 and a 12-month high of $305.00.

Vyome (NASDAQ:HIND) last issued its earnings results on Friday, November 14th. The company reported ($3.12) earnings per share (EPS) for the quarter. Vyome had a negative return on equity of 423.39% and a negative net margin of 270.58%.The business had revenue of $0.04 million for the quarter.

Vyome Company Profile

ReShape Lifesciences Inc, a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company’s product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract.